Publication | Closed Access

Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease

NeuropsychologyPsychoactive DrugPsychiatryPsychotropic MedicationMotor FunctioningPsychopharmacologyDepressionNeuropharmacologySocial SciencesRehabilitationNeuroscienceBiological PsychiatryDopamine Agonist PramipexoleDopamineMedicinePsychopathology